_id

690daa09ccc777a4e85d0894

Ticker

ADVM

Name

Adverum Biotechnologies Inc

Exchange

NASDAQ

Address

100 Cardinal Way, Redwood City, CA, United States, 94063

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://adverum.com

Description

Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases. Its lead product candidate is ixoberogene soroparvovec Ixo-vec, a single intravitreal injection gene therapy candidate used for the treatment of patients with wet age-related macular degeneration and diabetic macular edema which is in phase 2 clinical trials. The company is developing BGTF-027 (AAV.7m8-L-opsin), a novel gene therapy product candidate designed to deliver a functional copy of the OPN1LW gene to the foveal cones of patients suffering from blue cone monochromacy. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; GenSight Biologics; Ray Therapeutics; Lexeo Therapeutics; and Virovek, Inc. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Last Close

4.36

Volume

234247

Current Price

4.36

Change

0

Last Updated

2025-11-28T11:52:49.239Z

Image

data:image/webp;base64,UklGRmQBAABXRUJQVlA4IFgBAADwCACdASpAAEAAPrVOoEsnJCMhsBQKAOAWiWQAxrhSFKQtreucuMqkx0cQG/r1L138AkR1YbJFKcrL1Ge68sDUWTd9aR9fHQZ/RYiOmY3oAAD++Z9y+i9AkW6gotBXritdzLQjKUlMe07UqeHcp2dnamNUEUS0KK+FSMecwmFsQEYfSTCR2FqXnr2/KgK4oYt2ySEJJtW81CaCWFw3j9PufocjFIlUPtoYYQb4WWu1Nsxo99R0aUpYAHX4Yzbp34aiutC1QrpLuQ7GFkvkE9yE6AYMjy8eSmbMLJ2DQ5m7JlpphOA1Wv+P2XeaYxCLh+oqNsfmdXf/TV6L/ugrIjwrKnA3pE01wem7iOWbR2M+J1WyReQaHR6o3NVDs555EJ/0OSCnlUstH5KWl0QDLVRffUKcdnR5u9BXyuCyG7LwAm6uBejEwmEWBkH1D8SaA8L32jS4AAAAAA==

Ipo Date

2014-07-31T00:00:00.000Z

Market Cap

91842264

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9859999999999999

Sentiment Sources

6

Rating

4.5714

Target Price

4.9

Strong Buy

5

Buy

1

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

465000

Gross Profit

-465000

Operating Expenses

46558000

Operating Income

-47023000

Interest Expense

-

Pretax Income

-47652000

Net Income

-47652000

Eps

-2.0288670328266702

Dividends Per Share

-

Shares Outstanding

22077467

Income Tax Expense

-

EBITDA

-47187000

Operating Margin

-

Total Other Income Expense Net

-629000

Cash

26060000

Short Term Investments

0

Receivables

-

Inventories

-

Total Current Assets

28909000

Property Plant Equipment

39493000

Total Assets

72401000

Payables

12459000

Short Term Debt

5814000

Long Term Debt

-

Total Liabilities

128054000

Equity

-55653000

Depreciation

465000

Change In Working Capital

16646999

Cash From Operations

-28115000

Capital Expenditures

142000

Cash From Investing

1858000

Cash From Financing

9899000

Net Change In Cash

-16358000

PE

-

PB

-1.8400323432699046

ROE

85.62341652741092

ROA

-65.81677048659549

FCF

-28257000

Fcf Percent

-

Piotroski FScore

1

Health Score

39

Deep Value Investing Score

1

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

2

Growth Investing Score

2

Momentum Investing Score

2

Net Net Investing Score

1

Quality Investing Score

2.5

Value Investing Score

2.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

465000

Quarters > 0 > income Statement > gross Profit

-465000

Quarters > 0 > income Statement > operating Expenses

46558000

Quarters > 0 > income Statement > operating Income

-47023000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-47652000

Quarters > 0 > income Statement > net Income

-47652000

Quarters > 0 > income Statement > eps

-2.0288670328266702

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

23487000

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-47187000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-629000

Quarters > 0 > balance Sheet > cash

26060000

Quarters > 0 > balance Sheet > short Term Investments

0

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

28909000

Quarters > 0 > balance Sheet > property Plant Equipment

39493000

Quarters > 0 > balance Sheet > total Assets

72401000

Quarters > 0 > balance Sheet > payables

12459000

Quarters > 0 > balance Sheet > short Term Debt

5814000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

128054000

Quarters > 0 > balance Sheet > equity

-55653000

Quarters > 0 > cash Flow > net Income

-47652000

Quarters > 0 > cash Flow > depreciation

465000

Quarters > 0 > cash Flow > change In Working Capital

16646999

Quarters > 0 > cash Flow > cash From Operations

-28115000

Quarters > 0 > cash Flow > capital Expenditures

142000

Quarters > 0 > cash Flow > cash From Investing

1858000

Quarters > 0 > cash Flow > cash From Financing

9899000

Quarters > 0 > cash Flow > net Change In Cash

-16358000

Quarters > 0 > ratios > PE

-2.0288670328266702

Quarters > 0 > ratios > PB

-1.8400323432699046

Quarters > 0 > ratios > ROE

85.62341652741092

Quarters > 0 > ratios > ROA

-65.81677048659549

Quarters > 0 > ratios > FCF

-28257000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

39

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

535000

Quarters > 1 > income Statement > gross Profit

-535000

Quarters > 1 > income Statement > operating Expenses

49855000

Quarters > 1 > income Statement > operating Income

-49855000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-49191000

Quarters > 1 > income Statement > net Income

-49191000

Quarters > 1 > income Statement > eps

-2.341313660161828

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

21010000

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-49320000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

664000

Quarters > 1 > balance Sheet > cash

42418000

Quarters > 1 > balance Sheet > short Term Investments

1979000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

48391000

Quarters > 1 > balance Sheet > property Plant Equipment

44340000

Quarters > 1 > balance Sheet > total Assets

96179000

Quarters > 1 > balance Sheet > payables

4748000

Quarters > 1 > balance Sheet > short Term Debt

7363000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

116398000

Quarters > 1 > balance Sheet > equity

-20219000

Quarters > 1 > cash Flow > net Income

-49191000

Quarters > 1 > cash Flow > depreciation

535000

Quarters > 1 > cash Flow > change In Working Capital

7490000

Quarters > 1 > cash Flow > cash From Operations

-38767000

Quarters > 1 > cash Flow > capital Expenditures

120000

Quarters > 1 > cash Flow > cash From Investing

31904000

Quarters > 1 > cash Flow > cash From Financing

120000

Quarters > 1 > cash Flow > net Change In Cash

-6743000

Quarters > 1 > ratios > PE

-2.341313660161828

Quarters > 1 > ratios > PB

-4.530570255700084

Quarters > 1 > ratios > ROE

243.2909639448044

Quarters > 1 > ratios > ROA

-51.14526039987939

Quarters > 1 > ratios > FCF

-38887000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

39

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

-3600000

Quarters > 2 > income Statement > cost Of Revenue

683000

Quarters > 2 > income Statement > gross Profit

-683000

Quarters > 2 > income Statement > operating Expenses

48221000

Quarters > 2 > income Statement > operating Income

-48221000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-47019000

Quarters > 2 > income Statement > net Income

-47019000

Quarters > 2 > income Statement > eps

-2.24562995510555

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

20938000

Quarters > 2 > income Statement > income Tax Expense

-93000

Quarters > 2 > income Statement > EBITDA

-47538000

Quarters > 2 > income Statement > operating Margin

1339.4722222222222

Quarters > 2 > income Statement > total Other Income Expense Net

1202000

Quarters > 2 > balance Sheet > cash

49161000

Quarters > 2 > balance Sheet > short Term Investments

33922000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

89469000

Quarters > 2 > balance Sheet > property Plant Equipment

44719000

Quarters > 2 > balance Sheet > total Assets

137654000

Quarters > 2 > balance Sheet > payables

1819000

Quarters > 2 > balance Sheet > short Term Debt

7229000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

111232000

Quarters > 2 > balance Sheet > equity

26422000

Quarters > 2 > cash Flow > net Income

-47019000

Quarters > 2 > cash Flow > depreciation

683000

Quarters > 2 > cash Flow > change In Working Capital

215000

Quarters > 2 > cash Flow > cash From Operations

-42771000

Quarters > 2 > cash Flow > capital Expenditures

220000

Quarters > 2 > cash Flow > cash From Investing

31280000

Quarters > 2 > cash Flow > cash From Financing

239000

Quarters > 2 > cash Flow > net Change In Cash

-11491000

Quarters > 2 > ratios > PE

-2.24562995510555

Quarters > 2 > ratios > PB

3.4550632049050036

Quarters > 2 > ratios > ROE

-177.95397774581787

Quarters > 2 > ratios > ROA

-34.15738009792669

Quarters > 2 > ratios > FCF

-42991000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

11.941944444444445

Quarters > 2 > health Score

30

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

62217000

Quarters > 3 > income Statement > operating Income

-62217000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-60530000

Quarters > 3 > income Statement > net Income

-60530000

Quarters > 3 > income Statement > eps

-2.9033960092095166

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

20848000

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

1687000

Quarters > 3 > balance Sheet > cash

60652000

Quarters > 3 > balance Sheet > short Term Investments

65039000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

131300000

Quarters > 3 > balance Sheet > property Plant Equipment

45218000

Quarters > 3 > balance Sheet > total Assets

179841000

Quarters > 3 > balance Sheet > payables

1610000

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

109127000

Quarters > 3 > balance Sheet > equity

70714000

Quarters > 3 > cash Flow > net Income

-40931000

Quarters > 3 > cash Flow > depreciation

810000

Quarters > 3 > cash Flow > change In Working Capital

8932000

Quarters > 3 > cash Flow > cash From Operations

-28249000

Quarters > 3 > cash Flow > capital Expenditures

61000

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

239000

Quarters > 3 > cash Flow > net Change In Cash

-32199000

Quarters > 3 > ratios > PE

-2.9033960092095166

Quarters > 3 > ratios > PB

1.2854212744293916

Quarters > 3 > ratios > ROE

-85.59832564980061

Quarters > 3 > ratios > ROA

-33.65750857702081

Quarters > 3 > ratios > FCF

-28310000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

33

Valuation > metrics > PE

-2.0288670328266702

Valuation > metrics > PB

-1.8400323432699046

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

85.62341652741092

Profitability > metrics > ROA

-164.83448061157424

Profitability > final Score

55

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-101.1247311827957

Risk > final Score

-374

Risk > verdict

High

Liquidity > metrics > Current Ratio

1.582060964264215

Liquidity > metrics > Quick Ratio

1.582060964264215

Liquidity > final Score

90

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

45.44936795094996

Prev Valuations > 2

80

Prev Profitabilities > 0

55

Prev Profitabilities > 1

30

Prev Profitabilities > 2

15

Prev Risks > 0

-1516

Prev Risks > 1

-366

Prev Risks > 2

-118

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:12:01.100Z